Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Marker for Multiple Myeloma Oncogene

By HospiMedica staff writers
Posted on 28 Oct 2003
A monoclonal mouse antibody specific for the human multiple myeloma oncogene 1 (MUM1) is now available to laboratories.

This antibody is a tool for identifying surviving centrocytes and their progeny, understanding B-cell histogenesis, and characterizing Hodgkin's and Reed-Sternberg cells of classic Hodgkin's disease. More...
The antibody also has potential prognostic value since MUM1 expression correlates with clinical outcome in patients. Also, MUM1 will aid in correct tumor subclassification and should be included in routine diagnostic lymphoma marker panels, according to the developer, DakoCytomation (Copenhagen, Denmark).

DakoCytomation is an in vitro diagnostic company specializing in the identification of cancer markers on tissue samples obtained from biopsies and surgery. The company's products help doctors link diagnostic tests with specific therapies, thereby optimizing treatment. DakoCytomation states that it is the first company to offer an in vitro Class 1 antibody against this important antigen that has been approved by the US Food and Drug Administration (FDA) and also has the CE mark.




Related Links:
DakoCytomation

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Electrode Solution and Skin Prep
Signaspray
Gold Member
UGPIV Barrier and Securement
UltraDrape II
Portable Jaundice Management Device
Nymphaea
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.